1 completed, 1 not yet recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
Follow Ventrix, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients with Hypoplastic Left Heart Syndrome (HLHS) Ventrix Bio Extracellular Matrix - Hypoplastic Left Heart Syndrome | Phase 1 | Not yet recruiting | Emory University | 12 | 2025-08-01 | 2025-03-10 |
| A Study of VentriGel in Post-MI Patients VentriGel - Myocardial Infarction, Heart Failure | Phase 1 | Completed | Ventrix, Inc. | 15 | 2015-09-01 | 2019-10-25 |
Heart Failure (1) · Hypoplastic Left Heart Syndrome (1) · Myocardial Infarction (1) · Ventricular Remodeling (1)
United States (2)